
Glismart P 1mg/500mg/15mg Tablet ER
Marketer
LCB Pharma
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glismart P 1mg/500mg/15mg Tablet ER
Diabex Trio 1mg/500mg/15mg Extended-Release Tablets combine medications to manage blood glucose. This regimen, used alongside diet and exercise, improves glycemic control in adult type 2 diabetics. It enhances insulin effectiveness, reducing blood sugar. Dosage and frequency for Diabex Trio should strictly follow your physician's instructions. Take it with food to prevent stomach discomfort. If a dose is missed, take it immediately unless the next dose is imminent; avoid doubling the dose. Overdosing can cause hypoglycemia. Concurrent use with other antidiabetic drugs, alcohol, or skipped meals may increase hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Before starting Diabex Trio, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation prior to use. Kidney function tests will be performed before treatment commences. Limit alcohol consumption due to potential side effect exacerbation.
Uses of Glismart P 1mg/500mg/15mg Tablet ER
Managing type 2 diabetes
Major Benefits of Glismart P 1mg/500mg/15mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet without crushing, chewing, or breaking it. Glismart P 1mg/500mg/15mg Extended-Release Tablets should be administered with a meal.
Common Side effects of Glismart P 1mg/500mg/15mg Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glismart P 1mg/500mg/15mg Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the entire tablet without chewing, crushing, or dividing it. Glismart P 1mg/500mg/15mg Extended-Release tablets should be administered with a meal.
How Glismart P 1mg/500mg/15mg Tablet ER works:
Glismart P 1mg/500mg/15mg Extended-Release tablets contain glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. These medications act through different pathways to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood sugar levels. Metformin, a biguanide, decreases hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol and Glismart P 1mg/500mg/15mg ER tablet use is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glismart P 1mg/500mg/15mg Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers before prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glismart P 1mg/500mg/15mg tablet is likely not safe for breastfeeding mothers. Available evidence from humans indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyCAUTION
Patients with kidney impairment should use Glismart P 1mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glismart P 1mg/500mg/15mg Extended-Release tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should use Glismart P 1mg/500mg/15mg Extended-Release tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Glismart P 1mg/500mg/15mg Extended-Release tablets are contraindicated in individuals with severe liver disease.
What if you forget to take Glismart P 1mg/500mg/15mg Tablet ER :
Should you forget a Glismart P 1mg/500mg/15mg Extended-Release Tablet, take it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glismart P 1mg/500mg/15mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Treatment |
